Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing

Krämer A, Herth D, von Keyserlingk H, Ludwig WD, Hampl H, Sommer D, Hahn EG, Riecken E-O (1988)
Klinische Wochenschrift 66(15): 670-674.

Download
OA
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Volltext vorhanden für diesen Nachweis
Autor
; ; ; ; ; ; ;
Abstract / Bemerkung
The variation in immune responses to standard inoculation of the hepatitis-B virus vaccine suggest that host factors influence response in ways that are not presently understood. We studied 25 low/nonresponding health care workers (anti-HBs titer <50 IU/l) after the third inoculation of an experimental hepatitis-B vaccine to determine their immune status (through lymphocyte phenotypes) and HLA type. After application of a fourth inoculation, the seroconverting subjects showed only low anti-HBs levels; three male subjects remained anti-HBs negative. Twelve months after the fourth inoculation only 9 of 25 subjects (36%) maintained anti-HBs titer >10 IU/l. Almost all subjects had normal B-cell and CD-4 and CD-8 counts and ratios. Relative to other European populations HLA-A-10 (P<0.05), B-12 (P<0.025), CW-5 (P<0.05), DR-3 (P<0.025), and DR-5 (P<0.025) were increased, whereas DR-2 (P<0.05) was decreased. However, after correction of theP-values for the number of HLA antigens determined, these differences were no longer significant. Furthermore, these HLA types were not the same as those reported in other studies (except for DR-3). We suggest that larger sample sizes or even not yet available immunogenetic markers will be required to prove an "immunogenetic background" in low/nonresponders, if it exists.
Erscheinungsjahr
Zeitschriftentitel
Klinische Wochenschrift
Band
66
Ausgabe
15
Seite(n)
670-674
ISSN
eISSN
PUB-ID

Zitieren

Krämer A, Herth D, von Keyserlingk H, et al. Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing. Klinische Wochenschrift. 1988;66(15):670-674.
Krämer, A., Herth, D., von Keyserlingk, H., Ludwig, W. D., Hampl, H., Sommer, D., Hahn, E. G., et al. (1988). Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing. Klinische Wochenschrift, 66(15), 670-674. doi:10.1007/BF01726924
Krämer, A., Herth, D., von Keyserlingk, H., Ludwig, W. D., Hampl, H., Sommer, D., Hahn, E. G., and Riecken, E. - O. (1988). Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing. Klinische Wochenschrift 66, 670-674.
Krämer, A., et al., 1988. Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing. Klinische Wochenschrift, 66(15), p 670-674.
A. Krämer, et al., “Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing”, Klinische Wochenschrift, vol. 66, 1988, pp. 670-674.
Krämer, A., Herth, D., von Keyserlingk, H., Ludwig, W.D., Hampl, H., Sommer, D., Hahn, E.G., Riecken, E.-O.: Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing. Klinische Wochenschrift. 66, 670-674 (1988).
Krämer, Alexander, Herth, D., von Keyserlingk, H., Ludwig, W. D., Hampl, Hartmut, Sommer, D., Hahn, E. G., and Riecken, Ernst-Otto. “Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing”. Klinische Wochenschrift 66.15 (1988): 670-674.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Copyright Statement:
This Item is protected by copyright and/or related rights. [...]
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
1970-01-01T00:00:00Z

5 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.
Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM, Tang J., Hum Genet 126(5), 2009
PMID: 19597844
Defective antigen presentation by monocytes in ESRD patients not responding to hepatitis B vaccination: impaired HBsAg internalization and expression of ICAM-1 and HLA-DR/Ia molecules.
Stachowski J, Barth C, Pollok M, Michałkiewicz J, Madaliński K, Maciejewski J, Baldamis CA., Mediators Inflamm 4(1), 1995
PMID: 18475616
Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients.
Stachowski J, Kramer J, Füst G, Maciejewski J, Baldamus CA, Petrányi GG., Scand J Immunol 42(1), 1995
PMID: 7631146
The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, Marcus-Bagley D., J Exp Med 175(2), 1992
PMID: 1531063
Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination.
Hess G, Hingst V, Cseke J, Bock HL, Clemens R., Eur J Clin Microbiol Infect Dis 11(4), 1992
PMID: 1396753

28 References

Daten bereitgestellt von Europe PubMed Central.


P, 1971
[Vaccination of uremic patients against hepatitis B]
Bommer J, Deinhardt F, Jilg W, Darai D, Andrassy K, Ritz E., Dtsch. Med. Wochenschr. 108(48), 1983
PMID: 6641534

WGE, Hepatology 5(), 1985
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings.
Craven DE, Awdeh ZL, Kunches LM, Yunis EJ, Dienstag JL, Werner BG, Polk BF, Syndman DR, Platt R, Crumpacker CS., Ann. Intern. Med. 105(3), 1986
PMID: 2943202
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.
Dienstag JL, Werner BG, Polk BF, Snydman DR, Craven DE, Platt R, Crumpacker CS, Ouellet-Hellstrom R, Grady GF., Ann. Intern. Med. 101(1), 1984
PMID: 6233921

PR, 1982

W, Monogr Paediat 18(), 1986

FB, 1982
Immunogenicity of hepatitis B vaccine in renal transplant recipients.
Jacobson IM, Jaffers G, Dienstag JL, Tolkoff-Rubin NE, Cosimi AB, Delmonico F, Watkins E, Hinkle C, O'Rourke S, Russell PS., Transplantation 39(4), 1985
PMID: 3157246
[Persistence of antibodies against hepatitis B surface antigens after vaccination against hepatitis B]
Jilg W, Schmidt M, Zachoval R, Deinhardt F., Dtsch. Med. Wochenschr. 110(6), 1985
PMID: 3967610

AUTHOR UNKNOWN, 0
Studies on immunoregulatory mechanisms in acute and chronic hepatitis B.
Lemm G, Salzer K, Warnatz H., Clin. Exp. Immunol. 52(2), 1983
PMID: 6222854
Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.
Milich DR, Thornton GB, Neurath AR, Kent SB, Michel ML, Tiollais P, Chisari FV., Science 228(4704), 1985
PMID: 2408336
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W., N. Engl. J. Med. 311(8), 1984
PMID: 6235453
HL-A antigens and disease. Statistical and genetical considerations.
Svejgaard A, Jersild C, Nielsen LS, Bodmer WF., Tissue Antigens 4(2), 1974
PMID: 4134648
Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.
Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, DeVera A, Chen GT, Kellner A., N. Engl. J. Med. 307(24), 1982
PMID: 6755247
BODY SURFACE AREA IN HUMAN BEINGS.
VANGRAAN CH, WYNDHAM CH., Nature 204(), 1964
PMID: 14248724

JJ, 1979

ME, Transfusion 21(), 1981
[Active immunization against hepatitis B]
Wildgrube HJ, Classen M, von Lohr R, Kurth R, Brede HD., Dtsch. Med. Wochenschr. 109(7), 1984
PMID: 6230216

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 2971838
PubMed | Europe PMC

Suchen in

Google Scholar